Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
Phase 1
Recruiting
- Conditions
- Advanced Solid Tumor
- Interventions
- First Posted Date
- 2024-02-08
- Last Posted Date
- 2025-10-29
- Lead Sponsor
- Strand Therapeutics Inc.
- Target Recruit Count
- 108
- Registration Number
- NCT06249048
- Locations
- 🇺🇸
HonorHealth Research and Innovation Institute, Scottsdale, Arizona, United States
🇺🇸Cleveland Clinic, Cleveland, Ohio, United States
🇺🇸Huntsman Cancer Institute - University of Utah, Salt Lake City, Utah, United States
News
No news found